Tag: Weight Loss
New Side Effects Reported for GLP-1 RA Weight-Loss Drugs
FDA is investigating reports of hair loss, aspiration, and suicidal thoughts among people taking the medications
One-Third of Patients Persist on Antiobesity Medications at Six Months
Semaglutide associated with the highest persistence at one year
Quality of Low-Carb Diets Affects Weight Change in U.S. Adults
Weight gain seen in association with animal and unhealthy low-carb diets; weight loss linked to vegetable, healthy low-carb diets
FDA Warns of Counterfeit Ozempic
New Poll Finds Older Americans Believe Medicare Should Cover Weight-Loss Drugs
A 2003 law currently prohibits Medicare from covering medications specifically for weight loss
USPSTF Recommends Behavioral Interventions for Pediatric Weight Loss
Intensive behavioral interventions recommended for children and teens aged older than 6 years with high BMI
Continuing Tirzepatide Leads to Maintenance of Weight Reduction
Continued tirzepatide treatment maintains and augments initial weight reduction seen in first 36 weeks
Slow-to-Moderate Weight Loss Linked to Lower Mortality in Knee, Hip OA
Weight loss has dose-response protective effect on incident hypertension, type 2 diabetes, venous thromboembolism
Eli Lilly Says Its New Weight-Loss Drug, Zepbound, Is Now Available
Tirzepatide, the active ingredient in Zepbound, had already been approved by the FDA as a treatment for type 2 diabetes
AHA: Semaglutide Cuts Risk for CVD Events in Patients Without Diabetes
Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity
